Pharmacokinetics and Safety Profile of CKD-333
NCT03659149
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Dyslipidemias
Interventions
DRUG:
CKD-333 formulation I
DRUG:
CKD-333 formulation II
DRUG:
CKD-330+D086
Sponsor
Chong Kun Dang Pharmaceutical